Post coronavirus disease- 19 invasive renal and gastrointestinal mucormycosis

Indian J Med Microbiol. 2022 Jul-Sep;40(3):462-464. doi: 10.1016/j.ijmmb.2022.03.006. Epub 2022 May 6.

Abstract

A 68-year-old female patient who was treated with anti-viral, steroids and biologics for coronavirus disease- 19 (COVID- 19) infection presented to our facility following right abdominal and flank pain since a week. Initially attributed to pancreatitis and right sided pyelonephritis, it was diagnosed as mucormycosis on KOH mount following CT-guided renal biopsy. She underwent right total nephrectomy and Whipple's surgery followed by Isavuconazole and liposomal Amphotericin B. This is a rare presentation of renal and gastrointestinal mucormycosis in a patient without diabetes mellitus following COVID- 19 infection. High suspicion and early diagnosis help in timely treatment of this life-threatening infection.

Keywords: Coronavirus disease- 19; Gastrointestinal mucormycosis; Renal mucormycosis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents / therapeutic use
  • COVID-19* / complications
  • Coronavirus*
  • Female
  • Humans
  • Kidney
  • Mucormycosis* / diagnosis
  • Mucormycosis* / drug therapy
  • Mucormycosis* / pathology

Substances

  • Antifungal Agents